These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15481766)

  • 41. Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension.
    Shah S; Hermanowski-Vosatka A; Gibson K; Ruck RA; Jia G; Zhang J; Hwang PM; Ryan NW; Langdon RB; Feig PU
    J Am Soc Hypertens; 2011; 5(3):166-76. PubMed ID: 21419745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood pressure responses to whole-body cold exposure: effect of carvedilol.
    Komulainen S; Tähtinen T; Rintamäki H; Virokannas H; Keinänen-Kiukaanniemi S
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):637-42. PubMed ID: 11214769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension.
    Wong GW; Boyda HN; Wright JM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
    Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; ;
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circadian variation and blood pressure: response to rapid weight loss by hypocaloric hyponatraemic diet in obesity.
    DasGupta P; Brigden G; Ramhamdany E; Lahiri A; Baird IM; Raftery EB
    J Hypertens; 1991 May; 9(5):441-7. PubMed ID: 1649864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
    Daniels SR; Long B; Crow S; Styne D; Sothern M; Vargas-Rodriguez I; Harris L; Walch J; Jasinsky O; Cwik K; Hewkin A; Blakesley V;
    Pediatrics; 2007 Jul; 120(1):e147-57. PubMed ID: 17576783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of chronic treatment with beta-blockers on resting energy expenditure in obese hypertensive patients during a low-calorie and physical training program.
    Gondoni LA; Tagliaferri MA; Titon AM; Nibbio F; Liuzzi A; Leonetti G
    Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):232-7. PubMed ID: 14650356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
    Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH; Souza ER
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men.
    Kirby RS
    Urology; 1995 Aug; 46(2):182-6. PubMed ID: 7542819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term weight loss with sibutramine: a randomized controlled trial.
    Wirth A; Krause J
    JAMA; 2001 Sep; 286(11):1331-9. PubMed ID: 11560538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension.
    Sharma AM; Golay A
    J Hypertens; 2002 Sep; 20(9):1873-8. PubMed ID: 12195131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
    Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
    Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D; Incledon T; Gaunaurd I; Schwartz H; Krieger D
    Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
    Eriksson JW; Jansson PA; Foley K; Lithell H
    J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
    Bakris G; Calhoun D; Egan B; Hellmann C; Dolker M; Kingma I;
    J Hypertens; 2002 Nov; 20(11):2257-67. PubMed ID: 12409965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.